Lakefront Biotherapeutics N.V. (LKFT)
R&D to Revenue
37.50%
Fiscal year · Period ending:

LKFT R&D to Revenue
What is r&d to revenue?
R&D spending as percentage of revenue.
LKFT r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it, in percentage points.
| Period ending | R&D to Revenue | Change |
|---|---|---|
| 37.4961% | −84.20 pts | |
| 121.6979% | +21.04 pts | |
| 100.6549% | −1.29 pts | |
| 101.9401% | +0.53 pts | |
| 101.4151% | −8.13 pts | |
| 109.5416% | +58.97 pts | |
| 50.5713% | −61.21 pts | |
| 111.7852% | −60.15 pts | |
| 171.931% | +64.17 pts | |
| 107.765% | −220.10 pts | |
| 327.8669% | +167.69 pts | |
| 160.1747% | +88.00 pts | |
| 72.1719% | +13.27 pts | |
| 58.8972% | +58.90 pts | |
| 0% | 0.00 pts | |
| 0% | 0.00 pts | |
| 0% | −50.31 pts | |
| 50.3079% | +3.85 pts | |
| 46.4587% | +1.33 pts | |
| 45.1269% | −14.48 pts | |
| 59.6085% | −10.38 pts | |
| 69.9884% | — |
Frequently asked questions: LKFT r&d to revenue
What is Lakefront Biotherapeutics N.V. (LKFT)'s current r&d to revenue?
Lakefront Biotherapeutics N.V. (LKFT)'s latest reported r&d to revenue (Fiscal year) is 37.50% as of Dec 31, 2025. R&D spending as percentage of revenue.
How much historical r&d to revenue data is available for LKFT?
Stock Alarm Pro provides 22 dated annual fiscal periods observations for Lakefront Biotherapeutics N.V. (LKFT)'s r&d to revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare LKFT's r&d to revenue to peers or set an alert?
You can open LKFT's r&d to revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on LKFT delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance